Market Closed -
Other stock markets
|
After market 03:19:19 pm | |||
2.63 EUR | +0.77% |
|
2.575 | -2.09% |
Apr. 25 | Heidelberg Pharma AG Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
Apr. 23 | Transcript : Heidelberg Pharma AG - Special Call |
Business Summary
Number of employees: 98
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antibody Drug Conjugates
100.0
%
| 19 | 100.0 % | 10 | 100.0 % | -46.75% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
48.1
%
| 8 | 44.3 % | 5 | 48.1 % | -42.22% |
United States
47.4
%
| 9 | 48.5 % | 5 | 47.4 % | -47.98% |
Rest of the World
2.5
%
| 1 | 3.9 % | 0 | 2.5 % | -66.71% |
Switzerland
1.5
%
| 0 | 0.3 % | 0 | 1.5 % | +178.85% |
Germany
0.6
%
| 1 | 3.0 % | 0 | 0.6 % | -89.07% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andreas Pahl
CEO | Chief Executive Officer | - | 11-12-31 |
Walter Miller
DFI | Director of Finance/CFO | - | 23-04-30 |
András Strassz
CTO | Chief Tech/Sci/R&D Officer | - | 21-02-28 |
Jörg Kemkowski
COO | Chief Operating Officer | - | 22-12-31 |
Sylvia Wimmer
IRC | Investor Relations Contact | - | 99-11-30 |
George Badescu
PRN | Corporate Officer/Principal | - | 21-10-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 61 | 05-04-28 | |
Georg F. Baur
BRD | Director/Board Member | 74 | 00-12-13 |
Birgit Kudlek
BRD | Director/Board Member | 57 | 12-05-24 |
Christof Hettich
CHM | Chairman | 64 | 10-05-20 |
Mathias Hothum
BRD | Director/Board Member | 58 | 15-07-29 |
Dong Zhou Liu
BRD | Director/Board Member | - | 22-06-27 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 46,604,977 | 9,027,536 ( 19.37 %) | 0 | 19.37 % |
Company contact information
Heidelberg Pharma AG
Gregor-Mendel-Strasse 22
68526, Ladenburg
+49 6203 1009 0
http://heidelberg-pharma.com![address Heidelberg Pharma AG(HPHA)](https://cdn.zonebourse.com/static/address/16917562.png)
Sector
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.68% | 132M | |
+16.82% | 121B | |
+17.59% | 110B | |
+17.23% | 25.98B | |
-24.46% | 19.27B | |
-18.56% | 15.99B | |
-18.23% | 15.66B | |
-47.75% | 14.5B | |
+57.02% | 14.47B | |
+5.09% | 13.91B |
- Stock Market
- Equities
- HPHA Stock
- Company Heidelberg Pharma AG